Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1.5000
0.0000
(0.00%)
At close: April 4 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 8 | 14 |
| Avg. Estimate | -- | -- | 2.29B | 3.42B |
| Low Estimate | -- | -- | 2.24B | 2.87B |
| High Estimate | -- | -- | 2.37B | 4.3B |
| Year Ago Sales | -- | -- | 1.72B | 2.29B |
| Sales Growth (year/est) | -- | -- | 33.41% | 49.41% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| REGMF | -- | -- | -- | -- |
| S&P 500 | 6.59% | 6.64% | 9.81% | 16.08% |
Related Tickers
BPMC Blueprint Medicines Corporation
81.68
-6.23%
LEGN Legend Biotech Corporation
32.01
-2.65%
BMRN BioMarin Pharmaceutical Inc.
60.26
-10.70%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.5300
-5.94%
BHVN Biohaven Ltd.
18.59
-9.54%
SLNO Soleno Therapeutics, Inc.
67.48
-6.49%
CYTK Cytokinetics, Incorporated
37.36
-7.80%
SMMT Summit Therapeutics Inc.
17.36
-8.20%
REGN Regeneron Pharmaceuticals, Inc.
573.45
-6.09%